Efficacy of halopeRIdol to decrease the burden of Delirium In adult Critically ill patiEnts (EuRIDICE): study protocol for a prospective randomised multi-centre double-blind placebo-controlled clinical trial in the Netherlands

Introduction Delirium in critically ill adults is associated with prolonged hospital stay, increased mortality and greater cognitive and functional decline. Current practice guideline recommendations advocate the use of non-pharmacological strategies to reduce delirium. The routine use of scheduled haloperidol to treat delirium is not recommended given a lack of evidence regarding its ability to resolve delirium nor improve relevant short-term and longer-term outcomes. This study aims to evaluate the efficacy and safety of haloperidol for the treatment of delirium in adult critically ill patie... Mehr ...

Verfasser: Smit, Lisa
Trogrlić, Zoran
Devlin, John W
Osse, Robert-Jan
Ponssen, Huibert H
Slooter, Arjen J C
Hunfeld, Nicole G M
Rietdijk, Wim J R
Gommers, Diederik
van der Jagt, Mathieu
Dokumenttyp: Artikel
Erscheinungsdatum: 2020
Reihe/Periodikum: BMJ Open ; volume 10, issue 9, page e036735 ; ISSN 2044-6055 2044-6055
Verlag/Hrsg.: BMJ
Schlagwörter: General Medicine
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26825793
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://dx.doi.org/10.1136/bmjopen-2019-036735